These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3695894)

  • 21. ["Membrane attack complex" formation in hemodialysis treatment].
    Hauser AC; Derfler K; Stockenhuber F; Janata O; Balcke P
    Wien Klin Wochenschr; 1990 Mar; 102(5):140-2. PubMed ID: 2321381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membranes for blood purification: state of the art and new developments.
    Strathmann H; Göhl H
    Contrib Nephrol; 1990; 78():119-40; discussion 140-1. PubMed ID: 2225829
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of the complement system in the origin of respiratory insufficiency in patients on hemodialysis].
    Neĭmark MI
    Klin Med (Mosk); 1991 Nov; 69(11):79-81. PubMed ID: 1808418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
    Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research on dialyzers with improved biocompatibility.
    van der Steen A
    Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hemodialysis membranes: a historical perspective, current state and future prospect.
    Cheung AK; Leypoldt JK
    Semin Nephrol; 1997 May; 17(3):196-213. PubMed ID: 9165649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience with the multiple use of dialyzers].
    Strokov AG; Poz IaL; Baeva LB; Levitskiĭ ER; Annenkov AE; Rud'ko IA; Kubatiev AA
    Ter Arkh; 1994; 66(6):60-5. PubMed ID: 7940372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Locatelli F
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691051
    [No Abstract]   [Full Text] [Related]  

  • 29. [Beta 2-microglobulin kinetics during hemodialysis with different membranes].
    Stetsiuk EA; Siniukhin VN; Danilkov AP; Shpazhnikova NS; Nikolaeva NP; Khamaganova EG
    Urol Nefrol (Mosk); 1995; (3):18-20. PubMed ID: 7618215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Friedman EA
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691049
    [No Abstract]   [Full Text] [Related]  

  • 31. Complement activation and C1q binding activity in haemodialysis.
    Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunologic alterations associated with chronic hemodialysis.
    Rus HG; Cristea A; Gherman M; Niculescu F; Gavan M
    Med Interne; 1983; 21(4):289-95. PubMed ID: 6658343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients.
    Schiffl H
    Nephrol Dial Transplant; 1995; 10(6):911-2. PubMed ID: 7566634
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of two different dialysis membranes on leukocyte adhesion and aggregation.
    Hernandez MR; Palomo M; Fuste B; Carbó C; Collado S; Cases A; Escolar G
    Nephron Clin Pract; 2007; 106(1):c1-8. PubMed ID: 17347577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study of the Limulus amebocyte lysate-reactive substances flushed from cellulose hemodialysis membranes].
    Strokov AG; Baeva LB; Levitskiĭ ER; Tiagny-Riadno LI
    Urol Nefrol (Mosk); 1993; (3):41-4. PubMed ID: 7941162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified leukopenic response and complement activation during dialyzer reuse.
    Nakamura Y; Ozawa K; Akiba T; Matsui N; Yoshiyama N; Nakagawa S; Takeuchi J
    Proc Clin Dial Transplant Forum; 1980; 10():237-9. PubMed ID: 6810348
    [No Abstract]   [Full Text] [Related]  

  • 39. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T; Krajewska M
    Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of hemodialysis on the level of complement in chronic renal insufficiency].
    Iarmolinskiĭ IS; Sochnev AM; Chernevskis KhK
    Ter Arkh; 1976; 48(7):91-4. PubMed ID: 996750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.